Sernova Secures Commercial Rights to Proprietary Stem Cell Derived Technologies – MarketWatch
|
Sernova Secures Commercial Rights to Proprietary Stem Cell Derived Technologies
MarketWatch “This agreement provides us with a proprietary source of stem cell derived glucose responsive therapeutic cells. When placed within Sernova’s prevascularized Cell Pouch(TM), and protected locally from immune system attack, we believe that Sernova has … |
|
Sernova Secures Commercial Rights to Proprietary Stem Cell Derived Technologies
MarketWatch “This agreement provides us with a proprietary source of stem cell derived glucose responsive therapeutic cells. When placed within Sernova’s prevascularized Cell Pouch(TM), and protected locally from immune system attack, we believe that Sernova has … |
|
Sernova Secures Commercial Rights to Proprietary Stem Cell Derived Technologies
Stockhouse “This agreement provides us with a proprietary source of stem cell derived glucose responsive therapeutic cells. When placed within Sernova’s prevascularized Cell Pouch™, and protected locally from immune system attack, we believe that Sernova has the … |
Press Herald |
Federal grant boosts Maine Medical Center’s effort to grow kidneys from stem cells
Press Herald Adult stem cells have the potential to become almost any kind of cell, and researchers hope to develop ways to use the cells to treat a range of illnesses. But research is just beginning, and few stem cell therapies have been approved, according to the … |
Minneapolis Star Tribune |
Experts: More action needed to protect patients from experimental stem cell …
Minneapolis Star Tribune WASHINGTON — Federal officials need to do more to prevent for-profit stem cell clinics from exploiting and potentially injuring patients, according to an article published in a leading medical journal. The New England Journal of Medicine commentary … Beware Unregulated Stem Cell Treatments, Experts WarnHealthDay |